Physician profile
Murray L Shames
NPI 1225040330
$143,713.20
in general payments reported to CMS, 2019-2025
24 companies · $24K in 2025
The $24K reported for 2025 was more than what 95% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $11K · 2021: $9,181 · 2022: $8,838 · 2023: $23K · 2024: $13K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Consulting Fee: $8,615 · Food and Beverage: $7,394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $24,496.15 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,475.00 |
| Consulting Fee | $8,615.00 |
| Food and Beverage | $7,394.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $39,313.08 | 2019-2020 | |
| Cook Incorporated | $31,242.47 | 2019-2025 | Zenith, Zenith Alpha |
| W. L. Gore & Associates, INC. | $28,584.16 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Product In Development, Gore Viabahn Vbx Balloon Expandable Endo |
| Ge Healthcare | $24,570.71 | 2023-2025 | |
| Cook Medical LLC | $6,021.99 | 2019-2025 | Zenith, Zenith Spiral-Z, Zilver Ptx |
| Medtronic, INC. | $5,468.30 | 2021-2025 | Endurant Iis, Signia |
| Bolton Medical INC | $2,704.72 | 2019-2024 | Treo Abdominal Stent-Graft System |
| Endologix LLC | $1,695.24 | 2019 | |
| Penumbra, INC. | $1,228.97 | 2019-2024 | Penumbra System, Indigo System |
| Silk Road Medical, INC. | $509.82 | 2020-2022 | |
| Cook Research Incorporated | $495.27 | 2019-2025 | Zenith Alpha |
| Boston Scientific Corporation | $364.80 | 2020-2025 | Varithena Administration Pack, Enroute Transcarotid Neuroprotection System |
| Shockwave Medical, INC | $280.08 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Artivion, INC. | $249.41 | 2021 | |
| Abbott Laboratories | $241.18 | 2021-2023 | Jeti |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $141.15 | 2024 | Prolene |
| Kerecis Limited | $132.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Getinge USA Sales, LLC | $115.37 | 2019 | |
| Shape Memory Medical INC. | $104.96 | 2025 | Impede Embolization Plug |
| Cvrx, INC. | $88.76 | 2021 | |
| Inspiremd Ltd | $67.53 | 2025 | Cguard Prime Carotid Stent System |
| Medela LLC | $53.11 | 2022 | |
| Trisalus Life Sciences, INC. | $23.31 | 2025 | Trinav Infusion System |
| Argon Medical Devices, INC. | $16.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$21,292.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Murray Shames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.